Take a look at some of Friday's morning movers:
If money managers live and die by rotating between the two, you probably want to know what they mean.
Check out which companies are making headlines after-the-bell Thursday:
Vertex Pharmaceuticals is expected to report strong initial sales of its cystic fibrosis drug Kalydeco on Thursday as investors shift their attention away from the waning performance of the company's hepatitis C drug Incivek.
Stocks eased off their worst levels but still finished lower Thursday, following a volatile start, as investors remained on edge after some disappointing economic reports and amid jitters in the euro zone.
Earlier in the trading session, eBay shares were up as much as 16.6 percent, their best intraday gain since Oct. 2008.
Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010.
U.S. stock index futures struggled to hold gains Thursday after the weekly jobless claims report erased an earlier rally, but the better-than-expected Spanish bond auction and a round of solid earnings helped buoy the market.
Take a look at some of Thursday’s morning movers:
The Spectrum Pharmaceuticals growth party is over.
Yet another Vivus takeover rumor circulating through the market Tuesday got me thinking: When do most biotech and drug takeovers happen?
Stocks ended narrowly mixed in a lackluster session Wednesday following a weaker-than-expected existing home sales report and as investors were reluctant to jump in following the recent market rally.
After nearly a nine decade run, the “Breakfast of Champions” is on the ropes.
U.S. stock index futures hovered around the flatline Wednesday after a pullback in the previous session amid economic outlook worries over China.
Take a look at some of Wednesday morning’s early movers:
Fed Chairman Ben Bernanke heads back to Capitol Hill Wednesday, but there’s little chance he’ll enlighten markets on further monetary easing or the continuation of existing programs.
Traders in all markets will be watching the bond market in the week ahead to see if higher interest rates are here to stay.
Here is “Mad Money” host Jim Cramer’s “Game Plan” for the week of March 19-23.
Take a look at some of Monday morning’s early movers:
From the entire S&P 500, which stocks are analysts expecting to have the biggest pops? Find out!